Syneos Selling Solutions

Syneos Selling Solutions appears to refer to the commercial sales and field deployment capabilities of Syneos Health rather than to a separate standalone drug-development company. Syneos Health is an active, private biopharmaceutical services company that combines contract research, medical affairs, consulting, market access, patient support, and outsourced commercial field solutions for pharma and biotech clients. Its commercial organization provides field sales, virtual sales, account management, launch support, and commercialization services, supported by data, analytics, and its Kinetic platform. The company does not own a therapeutic pipeline in the traditional biotech sense; instead, it helps customers develop and commercialize therapies across multiple therapeutic areas. Syneos Health was taken private in 2023 by a consortium led by Elliott Investment Management, Patient Square Capital, and Veritas Capital.